280
Views
54
CrossRef citations to date
0
Altmetric
Research Article

The Human UDP-Glucuronosyltransferases: Structural Aspects and Drug Glucuronidation

, , , &
Pages 287-303 | Published online: 12 Aug 2003

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Satya Prakash Tripathi, Anuseema Bhadauriya, Abhijeet Patil & Abhay T. Sangamwar. (2013) Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights. Drug Metabolism Reviews 45:2, pages 231-252.
Read now
Sanna Kaivosaari, Moshe Finel & Mikko Koskinen. (2011) N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases. Xenobiotica 41:8, pages 652-669.
Read now
Mohamed-Eslam F. Mohamed, Tiffany Tseng & Reginald F. Frye. (2010) Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity. Xenobiotica 40:10, pages 663-669.
Read now
Chantal Guillemette, Eric Lévesque, Mario Harvey, Judith Bellemare & Vincent Menard. (2010) UGT genomic diversity: beyond gene duplication. Drug Metabolism Reviews 42:1, pages 24-44.
Read now

Articles from other publishers (50)

Paul M. Wehn, Song Yang, Jonas A. Grina, James P. Rizzi, Stephen T. Schlachter, Bin Wang, Rui Xu, Hanbiao Yang, Xinlin Du, Guangzhou Han, Keshi Wang, Robert M. Czerwinski, Emily L. Ged, Heli Huang, Megan M. Halfmann, Melissa A. Maddie, Emily R. Morton, Sarah R. Olive, Huiling Tan, Shanhai Xie, John A. Josey & Eli M. Wallace. (2023) Lead change of a HIF-2α antagonist guided by multiparameter optimization and utilization of an Olp→π*Ar interaction. Medicinal Chemistry Research 32:7, pages 1510-1531.
Crossref
Aneta Jaszczyk, Adrian M. Stankiewicz, Joanna Goscik, Alicja Majewska, Tadeusz Jezierski & Grzegorz R. Juszczak. (2023) Overnight Corticosterone and Gene Expression in Mouse Hippocampus: Time Course during Resting Period. International Journal of Molecular Sciences 24:3, pages 2828.
Crossref
Pierre-Alain Burnouf, Steve R. Roffler, Chia-Ching Wu & Yu-Cheng Su. (2022) Glucuronides: From biological waste to bio-nanomedical applications. Journal of Controlled Release 349, pages 765-782.
Crossref
Hui-Lin Pang, Guang-Hao Zhu, Qi-Hang Zhou, Chun-Zhi Ai, Ya-Di Zhu, Ping Wang, Tong-Yi Dou, Yang-Liu Xia, Hong Ma & Guang-Bo Ge. (2022) Discovery and Characterization of the Key Constituents in Ginkgo biloba Leaf Extract With Potent Inhibitory Effects on Human UDP-Glucuronosyltransferase 1A1. Frontiers in Pharmacology 13.
Crossref
Francesca Truzzi, Camilla Tibaldi, Yanxin Zhang, Giovanni Dinelli & Eros D′Amen. (2021) An Overview on Dietary Polyphenols and Their Biopharmaceutical Classification System (BCS). International Journal of Molecular Sciences 22:11, pages 5514.
Crossref
Serena Mostarda, Daniela Passeri, Andrea Carotti, Bruno Cerra, Carolina Colliva, Tiziana Benicchi, Antonio Macchiarulo, Roberto Pellicciari & Antimo Gioiello. (2018) Synthesis, physicochemical properties, and biological activity of bile acids 3-glucuronides: Novel insights into bile acid signalling and detoxification. European Journal of Medicinal Chemistry 144, pages 349-358.
Crossref
Huma Mehboob, Imtiaz Mahmood Tahir, Tahir Iqbal, Naheed Akhter, Naveed Munir & Muhammad Riaz. 2017. Genetic Polymorphisms. Genetic Polymorphisms.
Yu Zheng, Jee Min, Doyun Kim, Jung Park, Sung-Wook Choi, Eun Lee, Kun Na & Soo Bae. (2016) In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions. Molecules 21:8, pages 1052.
Crossref
Souzan B. Yanni. 2015. Translational ADMET for Drug Therapy. Translational ADMET for Drug Therapy 63 110 .
Laura Marín, Elisa M. Miguélez, Claudio J. Villar & Felipe Lombó. (2015) Bioavailability of Dietary Polyphenols and Gut Microbiota Metabolism: Antimicrobial Properties. BioMed Research International 2015, pages 1-18.
Crossref
A. Buettner, M. Wagenstaller & J. Beauchamp. 2015. Flavour Development, Analysis and Perception in Food and Beverages. Flavour Development, Analysis and Perception in Food and Beverages 387 407 .
Masamitsu Maekawa, Miki Shimada, Takashi Iida, Junichi Goto & Nariyasu Mano. (2014) Tandem mass spectrometric characterization of bile acids and steroid conjugates based on low-energy collision-induced dissociation. Steroids 80, pages 80-91.
Crossref
Willem G.E.J. Schoonen, Walter M.A. Westerink, Femke M. van de Water & Horbach G. Jean. 2013. High-Throughput Screening Methods in Toxicity Testing. High-Throughput Screening Methods in Toxicity Testing 33 75 .
Olivier Bouché & Pierre Laurent-PuigT. Lecomte. 2013. Médecine personnalisée en cancérologie digestive. Médecine personnalisée en cancérologie digestive 93 104 .
Pierre Laurent-Puig, Thierry Lecomte, Marie-Anne Loriot, Valerie Boige & Helene Blons. 2013. Biomarkers in Oncology. Biomarkers in Oncology 249 273 .
Porntipa Korprasertthaworn, Andrew Rowland, Benjamin C. Lewis, Peter I. Mackenzie, Krongtong Yoovathaworn & John O. Miners. (2012) Effects of amino acid substitutions at positions 33 and 37 on UDP-glucuronosyltransferase 1A9 (UGT1A9) activity and substrate selectivity. Biochemical Pharmacology 84:11, pages 1511-1521.
Crossref
Alexander V. LyubimovRonald E. Savage. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 38 .
Liping Ma, Jianguo Sun, Ying Peng, Rong Zhang, Feng Shao, Xiaoling Hu, Jianping Zhu, Xiaojin Wang, Xuefang Cheng, Yinci Zhu, Ping Wan, Dong Feng, Hui Wu & Guangji Wang. (2012) Glucuronidation of Edaravone by Human Liver and Kidney Microsomes: Biphasic Kinetics and Identification of UGT1A9 as the Major UDP-Glucuronosyltransferase Isoform. Drug Metabolism and Disposition 40:4, pages 734-741.
Crossref
Daniela Buchheit, Ellen I. Schmitt, Daniel Bischoff, Thomas Ebner & Matthias Bureik. (2011) S -Glucuronidation of 7-mercapto-4-methylcoumarin by human UDP glycosyltransferases in genetically engineered fission yeast cells . bchm 392:12, pages 1089-1095.
Crossref
Daniela Buchheit,Ellen I. Schmitt,Daniel Bischoff,Thomas Ebner,Matthias Bureik,. (2011) S-Glucuronidation of 7-mercapto-4-methylcoumarin by human UDP glycosyltransferases in genetically engineered fission yeast cells. Biological Chemistry, pages ---.
Crossref
Mohamed-Eslam F. Mohamed & Reginald F. Frye. (2011) Inhibitory Effects of Commonly Used Herbal Extracts on UDP-Glucuronosyltransferase 1A4, 1A6, and 1A9 Enzyme Activities. Drug Metabolism and Disposition 39:9, pages 1522-1528.
Crossref
Ted W. Johnson, Steven P. Tanis, Scott L. Butler, Deepak Dalvie, Dorothy M. DeLisle, Klaus R. Dress, Erik J. Flahive, Qiyue Hu, Jon E. Kuehler, Atsuo Kuki, Wen Liu, Guy A. McClellan, Qinghai Peng, Michael B. Plewe, Paul F. Richardson, Graham L. Smith, Jim Solowiej, Khanh T. Tran, Hai Wang, Xiaoming Yu, Junhu Zhang & Huichun Zhu. (2011) Design and Synthesis of Novel N -Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors . Journal of Medicinal Chemistry 54:9, pages 3393-3417.
Crossref
Steven P. Tanis, Michael B. Plewe, Ted W. Johnson, Scott L. Butler, Deepak Dalvie, Dorothy DeLisle, Klaus R. Dress, Qiyue Hu, Buwen Huang, Jon E. Kuehler, Atsuo Kuki, Wen Liu, Qinghai Peng, Graham L. Smith, Jim Solowiej, Khanh T. Tran, Hai Wang, Anle Yang, Chunfeng Yin, Xiaoming Yu, Junhu Zhang & Huichun Zhu. (2010) Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PK. Bioorganic & Medicinal Chemistry Letters 20:24, pages 7429-7434.
Crossref
Hui-Man Cheng, Chia-Cheng Li, Calvin Yu-Chian Chen, Hsin-Yi Lo, Wen-Yu Cheng, Chang-Hsien Lee, Shi-Zhe Yang, Shih-Lu Wu, Chien-Yun Hsiang & Tin-Yun Ho. (2010) Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluation. Journal of Ethnopharmacology 132:2, pages 429-437.
Crossref
Katriina Itäaho, Liisa Laakkonen & Moshe Finel. (2010) How Many and Which Amino Acids Are Responsible for the Large Activity Differences between the Highly Homologous UDP-Glucuronosyltransferases (UGT) 1A9 and UGT1A10?. Drug Metabolism and Disposition 38:4, pages 687-696.
Crossref
Olga Trubetskoy, Moshe Finel & Vladimir Trubetskoy. (2008) High-throughput screening technologies for drug glucuronidation profiling. Journal of Pharmacy and Pharmacology 60:8, pages 1061-1067.
Crossref
Mohamed-Eslam F. Mohamed & Reginald F. Frye. (2010) Inhibition of Intestinal and Hepatic Glucuronidation of Mycophenolic Acid by Ginkgo biloba Extract and Flavonoids. Drug Metabolism and Disposition 38:2, pages 270-275.
Crossref
T. Pallmann, U. Jonas, M. Wagner, M. Thevis, H. Kaeferstein, M.A. Rothschild & K. Bender. (2010) Enzyme-assisted synthesis and structural characterization of pure benzodiazepine glucuronide epimers. European Journal of Pharmaceutical Sciences 39:4, pages 233-240.
Crossref
Nina Sneitz, Michael H. Court, Xiuling Zhang, Kaisa Laajanen, Karen K. Yee, Pamela Dalton, Xinxin Ding & Moshe Finel. (2009) Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3. Pharmacogenetics and Genomics 19:12, pages 923-934.
Crossref
W-Y Cheng, J-C Lien, C-Y Hsiang, S-L Wu, C-C Li, H-Y Lo, J-C Chen, S-Y Chiang, J-A Liang & T-Y Ho. (2009) Comprehensive evaluation of a novel nuclear factor-κB inhibitor, quinoclamine, by transcriptomic analysis. British Journal of Pharmacology 157:5, pages 746-756.
Crossref
Anna Alonen, Minna Gartman, Olli Aitio, Moshe Finel, Jari Yli-Kauhaluoma & Risto Kostiainen. (2009) Synthesis, structure characterization, and enzyme screening of clenbuterol glucuronides. European Journal of Pharmaceutical Sciences 37:5, pages 581-587.
Crossref
Anna Alonen, Moshe Finel & Risto Kostiainen. (2008) The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan. Biochemical Pharmacology 76:6, pages 763-772.
Crossref
Minoli A. Perera, Federico Innocenti & Mark J. Ratain. (2012) Pharmacogenetic Testing for Uridine Diphosphate Glucuronosyltransferase 1A1 Polymorphisms: Are We There Yet?. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:6, pages 755-768.
Crossref
A.-S. Patana, M. Kurkela, M. Finel & A. Goldman. (2008) Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases. Protein Engineering Design and Selection 21:9, pages 537-543.
Crossref
Yan Xiong, Anne-Sisko Patana, Michael J. Miley, Agnieszka K. Zielinska, Stacie M. Bratton, Grover P. Miller, Adrian Goldman, Moshe Finel, Matt R. Redinbo & Anna Radominska-Pandya. (2008) The First Aspartic Acid of the DQxD Motif for Human UDP-Glucuronosyltransferase 1A10 Interacts with UDP-Glucuronic Acid during Catalysis. Drug Metabolism and Disposition 36:3, pages 517-522.
Crossref
Anne-Sisko Patana, Mika Kurkela, Adrian Goldman & Moshe Finel. (2007) The Human UDP-Glucuronosyltransferase: Identification of Key Residues within the Nucleotide-Sugar Binding Site. Molecular Pharmacology 72:3, pages 604-611.
Crossref
Russell P. Kruzelock & William Short. (2007) Colorectal Cancer Therapeutics and the Challenges of Applied Pharmacogenomics. Current Problems in Cancer 31:5, pages 315-366.
Crossref
Lee Willoughby, Philip Batterham & Phillip J Daborn. (2007) Piperonyl butoxide induces the expression of cytochrome P450 and glutathioneS-transferase genes inDrosophila melanogaster. Pest Management Science 63:8, pages 803-808.
Crossref
Benjamin C. Lewis, Peter I. Mackenzie, David J. Elliot, Brian Burchell, C. Ramana Bhasker & John O. Miners. (2007) Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation. Biochemical Pharmacology 73:9, pages 1463-1473.
Crossref
M. Hirata-Koizumi, M. Saito, S. Miyake & R. Hasegawa. (2007) Adverse events caused by drug interactions involving glucuronoconjugates of zidovudine, valproic acid and lamotrigine, and analysis of how such potential events are discussed in package inserts of Japan, UK and USA. Journal of Clinical Pharmacy and Therapeutics 32:2, pages 177-185.
Crossref
M.J. De Groot, D.F.V. Lewis & S. Modi. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II 809 825 .
Taina Sten, Saana Qvisen, Päivi Uutela, Leena Luukkanen, Risto Kostiainen & Moshe Finel. (2006) Prominent but Reverse Stereoselectivity in Propranolol Glucuronidation by Human UDP-Glucuronosyltransferases 1A9 and 1A10. Drug Metabolism and Disposition 34:9, pages 1488-1494.
Crossref
Floris A. de Jong, Maja J.A. de Jonge, Jaap Verweij & Ron H.J. Mathijssen. (2006) Role of pharmacogenetics in irinotecan therapy. Cancer Letters 234:1, pages 90-106.
Crossref
. 2006. Molekulare Pharmakologie und Toxikologie. Molekulare Pharmakologie und Toxikologie 19 49 .
Moshe Finel, Xin Li, Dione Gardner-Stephen, Stacie Bratton, Peter I. Mackenzie & Anna Radominska-Pandya. (2005) Human UDP-Glucuronosyltransferase 1A5: Identification, Expression, and Activity. Journal of Pharmacology and Experimental Therapeutics 315:3, pages 1143-1149.
Crossref
Hee Seung Kim & Irving W. Wainer. (2005) The covalent immobilization of microsomal uridine diphospho-glucuronosyltransferase (UDPGT): Initial synthesis and characterization of an UDPGT immobilized enzyme reactor for the on-line study of glucuronidation. Journal of Chromatography B 823:2, pages 158-166.
Crossref
Maria Shipkova & Eberhard Wieland. (2005) Glucuronidation in therapeutic drug monitoring. Clinica Chimica Acta 358:1-2, pages 2-23.
Crossref
Karl Walter Bock & Christoph Köhle. 2005. Phase II Conjugation Enzymes and Transport Systems. Phase II Conjugation Enzymes and Transport Systems 57 75 .
. 2005. Drug Metabolism. Drug Metabolism 129 170 .
Mika Kurkela, Jouni Hirvonen, Risto Kostiainen & Moshe Finel. (2004) The interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specific, and may involve both monomers. Biochemical Pharmacology 68:12, pages 2443-2450.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.